An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation

Zhang Q, Liu C, Wu S, Zhong N, Qiu J, Fu W, You X

International Journal of Nanomedicine 2026, 21:614400

Published Date: 9 July 2026